Tolerability aspects in duloxetine-treated patients with depression: Should one use a lower starting dose in clinical practice?
Wilhelm S, Boess FG, Hegerl U, Mergl R, Linden M, Schacht A, Schneider E.Expert Opin Drug Saf. 2012 Jun 20. [Epub ahead of print] AbstractObjective: This study questions whether a lower starting dose of duloxetine (DLX) could be beneficial for patients with depression, in terms of tolerability and safety in routine clinical care. Research design […]